Olema Pharmaceuticals(OLMA.US) Director Sells US$17.45 Million in Common Stock

$Olema Pharmaceuticals(OLMA.US)$ Director Graham G. Walmsley sold 1.18 million shares of common stock on Jun 4, 2024 at an average price of $14.85 for a total value of $17.45 million.Source: Announcem

moomoo NewsJun 6 17:42 ET

Form 144 | Olema Pharmaceuticals(OLMA.US) Director Proposes to Sell 6.65 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Jun 6, $Olema Pharmaceuticals(OLMA.US)$ Director Logos Opportunities Fund II LP intends to sell 475K shares of its common stock on Jun 4, with a total market value of approxima

moomoo NewsJun 6 10:07 ET

Form 144 | Olema Pharmaceuticals(OLMA.US) Director Proposes to Sell 9.79 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Jun 6, $Olema Pharmaceuticals(OLMA.US)$ Director Logos Opportunities Fund I LP intends to sell 700K shares of its common stock on Jun 4, with a total market value of approximat

moomoo NewsJun 6 10:07 ET

Olema Pharmaceuticals(OLMA.US) Director Sells US$257.45K in Common Stock

$Olema Pharmaceuticals(OLMA.US)$ Director Harmon Cyrus sold 25,000 shares of common stock on May 31, Jun 3, 4, 2024 at an average price of $10.3 for a total value of $257.45K.Source: Announcement What

moomoo NewsJun 4 21:41 ET

Capital One Financial Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $26

Capital One Financial analyst Naureen Quibria maintains $Olema Pharmaceuticals(OLMA.US)$ with a buy rating, and maintains the target price at $26.According to TipRanks data, the analyst has a success

moomoo NewsJun 4 17:32 ET

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, June 04, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (("Olema" or "Olema Oncology", NASDAQ:OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and

GlobeNewswireJun 4 16:28 ET